How does retatrutide cause weight loss?
Retatrutide (code name LY3437943) acts on three receptors at once: glucagon, GIP and GLP-1.
GLP-1 / GIP / glucagon triple agonistUpdated
Short answer
Retatrutide (code name LY3437943) acts on three receptors at once: glucagon, GIP and GLP-1.[1]
In obese mice, the glucagon-receptor effect on energy expenditure was added to the calorie-reducing effect of the GIP and GLP-1 receptors; this is an animal finding.[1]
In adults with diabetes, higher retatrutide doses lowered self-reported hunger and tendency to overeat versus placebo, in an exploratory analysis.[2]
More questions on Retatrutide
More on Retatrutide
Sources
- 1LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept.Cell metabolism · 2022PMID 35985340Accessed 2 Oct 2026
- 2Appetite, eating attitudes, and eating behaviours during treatment with retatrutide in adults with type 2 diabetes: Results of a phase 2 study.Diabetes, obesity & metabolism · 2025PMID 40916752Accessed 2 Oct 2026
Found an error? Report a correction.